OUSTER INC (OUST)

US68989M2026 - Common Stock

9.66  +0.05 (+0.52%)

After market: 9.65 -0.01 (-0.1%)

Fundamental Rating

3

Taking everything into account, OUST scores 3 out of 10 in our fundamental rating. OUST was compared to 127 industry peers in the Electronic Equipment, Instruments & Components industry. While OUST seems to be doing ok healthwise, there are quite some concerns on its profitability. OUST shows excellent growth, but is valued quite expensive already.



1

1. Profitability

1.1 Basic Checks

In the past year OUST has reported negative net income.
OUST had a negative operating cash flow in the past year.
In the past 5 years OUST always reported negative net income.
In the past 5 years OUST always reported negative operating cash flow.

1.2 Ratios

OUST has a Return On Assets of -113.11%. This is amonst the worse of the industry: OUST underperforms 92.06% of its industry peers.
Looking at the Return On Equity, with a value of -208.22%, OUST is doing worse than 90.48% of the companies in the same industry.
Industry RankSector Rank
ROA -113.11%
ROE -208.22%
ROIC N/A
ROA(3y)-65.92%
ROA(5y)-111.47%
ROE(3y)-108.34%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 11.61%, OUST is doing worse than 74.60% of the companies in the same industry.
OUST's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for OUST so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 11.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.3%
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

OUST does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OUST has more shares outstanding
OUST has a better debt/assets ratio than last year.

2.2 Solvency

OUST has an Altman-Z score of -2.65. This is a bad value and indicates that OUST is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -2.65, OUST is not doing good in the industry: 82.54% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.24 indicates that OUST is not too dependend on debt financing.
OUST has a Debt to Equity ratio of 0.24. This is comparable to the rest of the industry: OUST outperforms 44.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z -2.65
ROIC/WACCN/A
WACC9.61%

2.3 Liquidity

OUST has a Current Ratio of 3.22. This indicates that OUST is financially healthy and has no problem in meeting its short term obligations.
OUST's Current ratio of 3.22 is fine compared to the rest of the industry. OUST outperforms 64.29% of its industry peers.
OUST has a Quick Ratio of 2.94. This indicates that OUST is financially healthy and has no problem in meeting its short term obligations.
OUST's Quick ratio of 2.94 is fine compared to the rest of the industry. OUST outperforms 74.60% of its industry peers.
Industry RankSector Rank
Current Ratio 3.22
Quick Ratio 2.94

7

3. Growth

3.1 Past

OUST shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -3.78%.
The Revenue has grown by 102.98% in the past year. This is a very strong growth!
The Revenue has been growing by 63.94% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-3.78%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q50%
Revenue 1Y (TTM)102.98%
Revenue growth 3Y63.94%
Revenue growth 5YN/A
Revenue growth Q2Q123.44%

3.2 Future

Based on estimates for the next years, OUST will show a very strong growth in Earnings Per Share. The EPS will grow by 24.88% on average per year.
Based on estimates for the next years, OUST will show a very strong growth in Revenue. The Revenue will grow by 69.79% on average per year.
EPS Next Y60.69%
EPS Next 2Y29.68%
EPS Next 3Y18.49%
EPS Next 5Y24.88%
Revenue Next Year40.82%
Revenue Next 2Y47.74%
Revenue Next 3Y52.86%
Revenue Next 5Y69.79%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OUST. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OUST. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

OUST's earnings are expected to grow with 18.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.68%
EPS Next 3Y18.49%

0

5. Dividend

5.1 Amount

No dividends for OUST!.
Industry RankSector Rank
Dividend Yield N/A

OUSTER INC

NYSE:OUST (5/3/2024, 7:10:45 PM)

After market: 9.65 -0.01 (-0.1%)

9.66

+0.05 (+0.52%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap435.28M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -113.11%
ROE -208.22%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 11.61%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.25
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.22
Quick Ratio 2.94
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-3.78%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y60.69%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)102.98%
Revenue growth 3Y63.94%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y